JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266511

Human KDELR2 (ELP-1) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

KDELR2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human KDELR2 (ELP-1) knockout HEK-293T cell line (AB266511)
  • Sanger seq

Lab

Sanger Sequencing - Human KDELR2 (ELP-1) knockout HEK-293T cell line (AB266511)

Sequencing chromatogram displaying sequence edit in exon 1

Sanger Sequencing - Human KDELR2 (ELP-1) knockout HEK-293T cell line (AB266511)
  • Sanger seq

Unknown

Sanger Sequencing - Human KDELR2 (ELP-1) knockout HEK-293T cell line (AB266511)

Homozygous : 1 bp insertion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266511-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266511 Human KDELR2 (ELP-1) knockout HEK-293T cell line", "number":"AB266511-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266511-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266511-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266511-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266511 Human KDELR2 (ELP-1) knockout HEK-293T cell line", "number":"AB266511-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266511-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266511 Human KDELR2 (ELP-1) knockout HEK-293T cell line", "number":"AB266511-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266511-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266511 Human KDELR2 (ELP-1) knockout HEK-293T cell line", "number":"AB266511-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
KDELR2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ELP-1 also known as Elongator complex protein 1 or KDEL receptor 2 is a protein with a molecular weight of approximately 150 kDa. This protein is an important component of the Elongator complex which is involved in transcriptional elongation by RNA polymerase II. ELP-1 is ubiquitously expressed in various tissues suggesting its significance across multiple cell types. Its presence within the Elongator complex a multi-subunit assembly facilitates the proper modification of tRNA impacting protein synthesis efficiency.
Biological function summary

ELP-1 plays an important role in facilitating the modification of tRNA wobble uridines. This allows for accurate and efficient translation of the genetic code into proteins. ELP-1 as a vital part of the Elongator complex also contributes to the acetylation of histones which impacts chromatin structure and gene expression regulation. The protein ensures that gene transcription proceeds effectively by interacting with different components of the transcription machinery.

Pathways

The Elongator complex including ELP-1 integrates into the transcriptional regulation and tRNA modification pathways. ELP-1 interacts with several proteins like RNA polymerase II during gene transcription. Another intersecting pathway includes the regulation of response to cellular stress as correct modification of tRNA maintains protein synthesis under stress conditions. Its functionality within these pathways illustrates its integral role in ensuring proper cellular response to environmental changes.

ELP-1 is linked to familial dysautonomia a neurodevelopmental disorder that affects autonomic nervous system functioning. Mutations in the IKBKAP gene encoding ELP-1 impair its function leading to the disease's manifestation. Additionally there is evidence suggesting ELP-1's involvement in multiple cancer types where altered elongator complex activity can affect tumor progression. In these contexts ELP-1's interactions with other proteins like IKBKAP become highly relevant for understanding the disease mechanisms and potentially developing therapeutic interventions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com